Table 3

Distribution of study covariates and hospital outcomes of patients with and without T2DM hospitalized with ventilator-associated pneumonia in Spain (2016–2017), after propensity score matching

T2DMNo T2DMP value
Male sex, n (%)358 (71.03)359 (71.23)0.945
Female sex, n (%)146 (28.97)145 (28.77)
Age, mean (SD)67.67 (9.68)68.25 (10.48)0.367
40–64 years, n (%)187 (37.1)167 (33.13)0.178
65–74 years, n (%)191 (37.9)186 (36.9)
≥75 years, n (%)126 (25)151 (29.96)
CCI, mean (SD)1.28 (0.97)1.22(1)0.370
Myocardial infarction, n (%)68 (13.49)69 (13.69)0.927
Congestive heart failure, n (%)115 (22.82)111 (22.02)0.763
Peripheral vascular disease, n (%)41 (8.13)37 (7.34)0.637
Cerebrovascular disease, n (%)105 (20.83)88 (17.46)0.174
Dementia, n (%)3 (0.6)4 (0.79)0.704
COPD, n (%)84 (16.67)78 (15.48)0.607
Rheumatoid disease, n (%)5 (0.99)3 (0.6)0.478
Peptic ulcer, n (%)16 (3.17)13 (2.58)0.572
Mild liver disease, n (%)31 (6.15)40 (7.94)0.268
Hemiplegia or paraplegia, n (%)39 (7.74)37 (7.34)0.811
Renal disease, n (%)72 (14.29)64 (12.7)0.461
Cancer, n (%)32 (6.35)40 (7.94)0.328
Moderate/severe liver disease, n (%)17 (3.37)15 (2.98)0.719
Metastatic cancer, n (%)16 (3.17)17 (3.37)0.860
AIDS, n (%)0 (0)0 (0)NA
Undergone surgery, n (%)371 (73.61)381 (75.6)0.469
Axial CT of thorax, n (%)28 (5.56)48 (9.52)0.017
Bronchial fibroscopy, n (%)28 (5.56)29 (5.75)0.892
Dialysis, n (%)86 (17.06)76 (15.08)0.391
Pressure ulcer, n (%)54 (10.71)50 (9.92)0.679
LOHS, mean (SD)47.41 (39.58)53.52 (51.18)0.034
IHM, n (%)220 (43.65)211 (41.87)0.567
  • CCI, Charlson Comorbidity Index; COPD, chronic obstructive pulmonary disease; IHM, in-hospital mortality; LOHS, length of hospital stay; NA, Not adequate; T2DM, type 2 diabetes mellitus.